Literature DB >> 23134557

ACTH-secreting Crooke cell carcinoma of the pituitary.

Gábor L Kovács1, Miklós Góth, Fabio Rotondo, Bernd W Scheithauer, Eivind Carlsen, Ali Saadia, Erika Hubina, László Kovács, István Szabolcs, Pál Nagy, Sándor Czirják, Zoltán Hanzély, Kálmán Kovács, Éva Horváth, Márta Korbonits.   

Abstract

PURPOSE: While pituitary adenomas are common, pituitary carcinomas are rare. It is unclear whether pituitary carcinomas arise de novo or evolve from adenomas.
METHODS: We studied the clinical characteristics and tissue samples from eight pituitary surgeries and the autopsy from a patient with pituitary carcinoma. A 16-year-old female patient was diagnosed with an aggressive Crooke cell macroadenoma. Following transsphenoidal surgery, clinical signs of Cushing disease quickly reappeared. During the 14-year course of the illness, eight pituitary surgeries, three courses of extracranial irradiation and two (90) Yttrium-DOTATOC treatments were undertaken. A bilateral adrenalectomy was performed. The patient died of metastatic disease and uncontrolled hypercortisolism due to an adrenal remnant. A systematic morphologic study (histologic staining, electron microscopy) of all available surgical and autopsy specimens was undertaken.
RESULTS: Brisk mitotic activity, high Ki-67 and p53 immunolabelling were present in the pituitary samples from the onset. High proportion of tumour cells showed irregular nuclei and large nucleoli, and gradual increase in MGMT staining was observed. The tumour remained of Crooke cell type throughout the course. Autopsy disclosed a postirradiation sarcoma in the pituitary area.
CONCLUSIONS: The question whether pituitary carcinomas arise de novo or transform from an adenoma cannot be answered at present with certainty.
© 2012 The Authors. European Journal of Clinical Investigation © 2012 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23134557     DOI: 10.1111/eci.12010

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  12 in total

Review 1.  Corticotrophic pituitary carcinoma with cervical metastases: case series and literature review.

Authors:  Frederick Yoo; Edward C Kuan; Anthony P Heaney; Marvin Bergsneider; Marilene B Wang
Journal:  Pituitary       Date:  2018-06       Impact factor: 4.107

Review 2.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

Review 3.  Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma).

Authors:  Nèle Lenders; Ann McCormack
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

Review 4.  Epidemiology and etiopathogenesis of pituitary adenomas.

Authors:  Elena D Aflorei; Márta Korbonits
Journal:  J Neurooncol       Date:  2014-01-31       Impact factor: 4.130

5.  Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience.

Authors:  G Giuffrida; F Ferraù; R Laudicella; O R Cotta; E Messina; F Granata; F F Angileri; A Vento; A Alibrandi; S Baldari; S Cannavò
Journal:  Endocr Connect       Date:  2019-05-01       Impact factor: 3.335

6.  Surgery, Octreotide, Temozolomide, Bevacizumab, Radiotherapy, and Pegvisomant Treatment of an AIP Mutation‒Positive Child.

Authors:  Pinaki Dutta; Kavita S Reddy; Ashutosh Rai; Anil K Madugundu; Hitendra S Solanki; Anil Bhansali; Bishan D Radotra; Narendra Kumar; David Collier; Donato Iacovazzo; Prakamya Gupta; Remya Raja; Harsha Gowda; Akhilesh Pandey; Jagtar Singh Devgun; Márta Korbonits
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

Review 7.  Multimodal Non-Surgical Treatments of Aggressive Pituitary Tumors.

Authors:  Tae Nakano-Tateno; Kheng Joe Lau; Justin Wang; Cailin McMahon; Yasuhiko Kawakami; Toru Tateno; Takako Araki
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-26       Impact factor: 5.555

Review 8.  Cervical Lymph Node Metastases from Central Nervous System Tumors: A Systematic Review.

Authors:  Andrés Coca-Pelaz; Justin A Bishop; Nina Zidar; Abbas Agaimy; Eloisa Maria Mello Santiago Gebrim; Vanni Mondin; Oded Cohen; Primož Strojan; Alessandra Rinaldo; Ashok R Shaha; Remco de Bree; Marc Hamoir; Antti A Mäkitie; Luiz P Kowalski; Nabil F Saba; Alfio Ferlito
Journal:  Cancer Manag Res       Date:  2022-03-09       Impact factor: 3.989

Review 9.  Aggressive pituitary neuroendocrine tumors: current practices, controversies, and perspectives, on behalf of the EANS skull base section.

Authors:  Sam Ng; Mahmoud Messerer; Julien Engelhardt; Michaël Bruneau; Jan Frederick Cornelius; Luigi Maria Cavallo; Giulia Cossu; Sebastien Froelich; Torstein R Meling; Dimitrios Paraskevopoulos; Henry W S Schroeder; Marcos Tatagiba; Idoya Zazpe; Moncef Berhouma; Roy T Daniel; Edward R Laws; Engelbert Knosp; Michael Buchfelder; Henri Dufour; Stéphane Gaillard; Timothée Jacquesson; Emmanuel Jouanneau
Journal:  Acta Neurochir (Wien)       Date:  2021-08-08       Impact factor: 2.816

10.  Temozolomide Nonresponsiveness in Aggressive Prolactinomas and Carcinomas: Management and Outcomes.

Authors:  Liza Das; Ashutosh Rai; Pravin Salunke; Chirag Kamal Ahuja; Ashwani Sood; Bishan Dass Radotra; Ridhi Sood; Márta Korbonits; Pinaki Dutta
Journal:  J Endocr Soc       Date:  2021-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.